Starzl T E, Hakala T R, Rosenthal J T, Iwatsuki S, Shaw B W
Surg Gynecol Obstet. 1982 Jun;154(6):819-25.
The postoperative convalescence period was analyzed for 42 consecutive patients who had cadaveric renal transplantation under therapy with cyclosporin A and steroids. Twenty-two of the patients underwent transplantation for the first time, and the other 20 had retransplantation. None of the recipients has died. With follow-up period of two to eight months, the survival rate of grafts is 96 per cent after first transplantation and 85 per cent after retransplantation. Immunosuppression with a standard regimen was used for all patients at the outset. Early convalescence was highly variable, often necessitating adjustments of cyclosporin A and steroid dosage to accommodate the possibilities of rejection or cyclosporin A nephrotoxicity, or both, simultaneously. Management problems were more frequent and complex in patients undergoing retransplantation. From the results, a classification of convalescence patterns was evolved, with recommendations about how standardized initial therapy should be adjusted if the renal graft does not function promptly or deteriorates later.
对42例接受尸体肾移植并使用环孢素A和类固醇治疗的连续患者的术后恢复期进行了分析。其中22例患者首次接受移植,另外20例进行了再次移植。所有受者均未死亡。随访时间为2至8个月,首次移植后移植物存活率为96%,再次移植后为85%。所有患者一开始均采用标准方案进行免疫抑制。早期恢复期差异很大,常常需要调整环孢素A和类固醇剂量,以应对排斥反应或环孢素A肾毒性或两者同时出现的可能性。再次移植患者的管理问题更为频繁和复杂。根据结果,制定了恢复期模式分类,并就肾移植不能迅速发挥功能或随后恶化时应如何调整标准化初始治疗提出了建议。